1.3 C
New York
Tuesday, January 31, 2023

Is Ardelyx Inc. (NASDAQ: ARDX) The Best Stock To Invest In?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Ardelyx Inc. (ARDX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.03, or 1.01%, to $2.99. The Ardelyx Inc. has recorded 63,045 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that FDA Grants Appeal for Ardelyx’s XPHOZAH® (tenapanor).

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Stocks Info

Ardelyx Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $2.96 and fluctuated between $2.9800 as its day high and $2.7004 as its day low. The current market capitalization of Ardelyx Inc. is $531.68M. A total of 7.0 million shares were traded on the day, compared to an average of 9.98M shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, ARDX has seen 1 BUY and 23 SELL insider trades, representing the acquisition of 567,000 and the disposition of 17,074 shares. Over the last 12 months, there were 13 BUYs and 74 SELLs from insiders. Insiders purchased 1,296,675 shares during that period but sold 613,626.

In the most recent transaction, Rosenbaum David P. sold 484 shares of ARDX for 1.95 per share on Nov 22. After the transaction, the Chief Development Officer now owns 88,885 company shares. In a previous transaction on Nov 22, Rosenbaum David P. sold 1,464 shares at 1.95 per share. ARDX shares that Chief Development Officer owns now total 300,994.

Among the insiders who sold shares, Rodriguez Susan disposed of 3,456 shares on Nov 22 at a per-share price of $1.95. This resulted in the Chief Commercial Officer holding 282,717 shares of ARDX after the transaction. In another insider transaction, GRAMMER ELIZABETH A sold 1,242 shares at $1.95 per share on Nov 22. Company shares held by the insider now total 254,868.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for ARDX in the last 3 months, the mean price target is $5.58 with high estimates of $8.00 and low estimates of $2.00. In terms of 52-week highs and lows, ARDX has a high of $3.05 and a low of $0.49.

As of this writing, ARDX has an earnings estimate of -$0.17 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$0.19. The company reported an EPS of -$0.21 in the last quarter, which was 4.50% higher than expectations of -$0.22.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARDX is Overweight with a score of 4.43. A total of 5 analysts rated the stock as Buy while 0 rated it as Overweight while 2 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles